Orbimed Advisors LLC’s Bristol-Myers Squibb Co Position
Does Orbimed Advisors LLC own Bristol-Myers Squibb Co (BMY)? Yes — 925.0K shares worth $56M (+1.11% of its 13F portfolio) as of Q1 2026, up from 775.0K shares the prior filed quarter.
Position Value
$56M
Q1 2026
Shares
925.0K
% of Portfolio
+1.11%
Quarters Held
20
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 925.0K | $56M | +1.11% |
| Q4 2025 | 775.0K | $42M | +0.85% |
| Q2 2023 | 1.49M | $95M | +1.72% |
| Q1 2023 | 2.34M | $162M | +3.18% |
| Q4 2022 | 2.58M | $186M | +3.56% |
| Q3 2022 | 2.58M | $184M | +3.41% |
| Q2 2022 | 2.52M | $194M | +3.51% |
| Q1 2022 | 2.61M | $190M | +3.09% |
| Q4 2021 | 4.34M | $271M | +3.48% |
| Q3 2021 | 4.52M | $267M | +2.94% |
| Q2 2021 | 4.52M | $302M | +3.05% |
| Q1 2021 | 4.52M | $285M | +2.67% |
| Q4 2020 | 3.55M | $220M | +1.93% |
| Q3 2020 | 3.55M | $214M | +2.69% |
| Q2 2020 | 2.88M | $169M | +2.39% |
| Q1 2020 | 2.47M | $138M | +2.32% |
| Q4 2019 | 1.70M | $109M | +1.56% |
| Q2 2019 | 1.35M | $61M | +0.94% |
| Q1 2019 | 1.20M | $57M | +0.88% |
| Q4 2018 | 505.9K | $26M | +0.49% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of BMY.